Gary Ingenito is Chief Med. & Reg. Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 51,391 shares of CPRX, which is worth approximately $1.13 Million. The most recent transaction as insider was on Aug 09, 2024, when has been sold 100,000 shares (Common Stock, par value $0.001 per share) at a price of $18.04 per share, resulting in proceeds of $1,804,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.4K
0% 3M change
33.95% 12M change
Total Value Held $1.13 Million

GARY INGENITO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2024
SELL
Open market or private sale
$1,804,000 $18.04 p/Share
100,000 Reduced 66.05%
51,391 Common Stock, par valu...
Aug 09 2024
BUY
Exercise of conversion of derivative security
$401,000 $4.01 p/Share
100,000 Added 39.78%
151,391 Common Stock, par valu...
Jun 05 2024
SELL
Open market or private sale
$1,292,800 $16.16 p/Share
80,000 Reduced 60.89%
51,391 Common Stock, par valu...
Jun 05 2024
BUY
Exercise of conversion of derivative security
$320,800 $4.01 p/Share
80,000 Added 37.84%
131,391 Common Stock, par valu...
Feb 15 2024
SELL
Payment of exercise price or tax liability
-
2,435 Reduced 4.52%
51,391 Common Stock, par valu...
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
10,000 Added 15.67%
53,826 Common Stock, par valu...
Dec 27 2023
SELL
Payment of exercise price or tax liability
-
3,541 Reduced 7.48%
43,826 Common Stock, par valu...
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
9,000 Added 15.97%
47,367 Common Stock, par valu...
Dec 06 2023
SELL
Open market or private sale
$701,000 $14.02 p/Share
50,000 Reduced 56.58%
38,367 Common Stock, par valu...
Dec 06 2023
BUY
Exercise of conversion of derivative security
$56,499 $1.13 p/Share
50,000 Added 36.14%
88,367 Common Stock, par valu...
Feb 15 2023
SELL
Payment of exercise price or tax liability
-
2,435 Reduced 5.97%
38,367 Common Stock, par valu...
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
10,000 Added 19.68%
40,802 Common Stock, par valu...
Dec 06 2022
SELL
Open market or private sale
$99,718 $16.85 p/Share
5,918 Reduced 16.12%
30,802 Common Stock, par valu...
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
14,667 Added 28.54%
36,720 Common Stock, par valu...
Sep 14 2022
SELL
Open market or private sale
$2,240,810 $15.67 p/Share
143,000 Reduced 86.64%
22,053 Common Stock, par valu...
Sep 14 2022
BUY
Exercise of conversion of derivative security
$619,190 $4.33 p/Share
143,000 Added 56.51%
110,053 Common Stock, par valu...
Jun 22 2022
SELL
Open market or private sale
$40,665 $6.61 p/Share
6,152 Reduced 21.81%
22,053 Common Stock, par valu...
Jun 22 2022
BUY
Exercise of conversion of derivative security
$25,408 $4.13 p/Share
6,152 Added 17.91%
28,205 Common Stock, par valu...
Jun 21 2022
SELL
Open market or private sale
$947,958 $6.59 p/Share
143,848 Reduced 86.71%
22,053 Common Stock, par valu...
Jun 21 2022
BUY
Exercise of conversion of derivative security
$594,092 $4.13 p/Share
143,848 Added 46.44%
165,901 Common Stock, par valu...
Dec 07 2021
SELL
Open market or private sale
$25,248 $6.99 p/Share
3,612 Reduced 14.07%
22,053 Common Stock, par valu...
Dec 07 2021
BUY
Exercise of conversion of derivative security
-
14,667 Added 36.37%
25,665 Common Stock, par valu...
Dec 22 2020
SELL
Open market or private sale
$12,655 $3.45 p/Share
3,668 Reduced 25.01%
10,998 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
14,666 Added 50.0%
14,666 Common Stock, par valu...
GI

Gary Ingenito

Chief Med. & Reg. Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX